Chemist + Druggist is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


GPhC could use covert surveillance to tackle pharmacy POM diversion

The GPhC could use covert surveillance to investigate pharmacists suspected of diverting prescription-only medicines (POMs) to the criminal market, it has told C+D.

The new powers to conduct “covert directed surveillance” were authorised under the Regulation of Investigatory Powers Act (RIPA) in July 2018 to be used as part of the General Pharmaceutical Council's (GPhC) inspections enforcement.

One example where the GPhC might use the powers is if it received intelligence that medicines were being diverted from the supply chain and sold illegally by pharmacy professionals, the regulator told C+D last month.

In February, the government's medicines watchdog said it was investigating 25 pharmacies for diverting POMs to the black market. Eight pharmacists had already been suspended from the GPhC register for their role in the investigation.

Test purchases and internet surveillance

Under the new powers, surveillance could mean “a GPhC inspector carrying out a series of test purchases… which includes surveillance over and above the transaction itself, and which is likely to result in obtaining private information about an individual”, the GPhC explained last month.

It could also mean “a GPhC inspector monitoring an individual over a period of time”, the GPhC said.

The surveillance might include “a hidden camera or other recording device” or “using the internet for intelligence gathering or as a surveillance tool if proportionate”, it added.

The regulator can carry out surveillance in public places, which includes pharmacies, but not in private homes or in vehicles, it said.

“Most will be done overtly”

Most of the surveillance will be done “overtly” with “nothing secretive or hidden” about it, the GPhC stressed.

Covert surveillance would only be used “as a last resort in an investigation” where “properly authorised, lawful, proportionate and necessary, and where there is no other reasonable and less intrusive means of obtaining the information required”, it explained.

The regulator stressed that it does not have the power to use covert human sources such as using an informant or someone acting undercover.

It has not yet used the powers, it added.

Read lawyer David Reissner's take on the GPhC's new covert surveillance powers.

Do you think covert surveillance is a reasonable way to investigate pharmacies under suspicion?

Related Content


Pharmacy Dispenser/ Technician
Bethnal Green North, London
Salary: Up to £30,000

Apply Now



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts